70 related articles for article (PubMed ID: 1737299)
1. Familial combined hyperlipoproteinemia.
Spence JD
CMAJ; 1992 Feb; 146(4):436, 438. PubMed ID: 1737299
[No Abstract] [Full Text] [Related]
2. Acanthosis nigricans caused by nicotinic acid: case report and review of the literature.
Stals H; Vercammen C; Peeters C; Morren MA
Dermatology; 1994; 189(2):203-6. PubMed ID: 8075456
[TBL] [Abstract][Full Text] [Related]
3. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
4. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of sustained-release niacin.
Knapp TR; Middleton RK
DICP; 1991 Mar; 25(3):253-4. PubMed ID: 2028632
[No Abstract] [Full Text] [Related]
6. Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital.
Fischer DJ; Knight LL; Vestal RE
West J Med; 1991 Oct; 155(4):410-2. PubMed ID: 1771885
[No Abstract] [Full Text] [Related]
7. Managing lipid disorders.
Becker G
Iowa Med; 1990 Apr; 80(4):207. PubMed ID: 2335469
[No Abstract] [Full Text] [Related]
8. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
[TBL] [Abstract][Full Text] [Related]
9. [Long-term treatment of hyperlipoproteinemia with etofibrate].
Bartz VT; Gatz J; Slotty C; Schröter C; Töle R; Wand P
Fortschr Med; 1993 Sep; 111(25):398-400. PubMed ID: 8406286
[TBL] [Abstract][Full Text] [Related]
10. Nutrition. Pilot study suggests high-dose niacin is safe and effective for some PHAs.
TreatmentUpdate; 2004 Oct; 16(6):6-7. PubMed ID: 17219680
[No Abstract] [Full Text] [Related]
11. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
[TBL] [Abstract][Full Text] [Related]
12. [Effects of bezafibrate in patients with combined hyperlipidemia].
Vílchez Joya R; Escobar Jiménez F; Campos MM; Torres E; Orduña R; Cabrera J; Núñez J
Med Clin (Barc); 1986 Feb; 86(5):190-4. PubMed ID: 3959651
[No Abstract] [Full Text] [Related]
13. [Etophylline clofibrate in the treatment of familial combined hyperlipoproteinemia].
Raslová K; Hucková M
Vnitr Lek; 1995 Apr; 41(4):240-2. PubMed ID: 7762188
[TBL] [Abstract][Full Text] [Related]
14. Side effects and complications. Extended-release high-dose niacin helps lower lipid levels.
TreatmentUpdate; 2005 Dec; 17(7):7-8. PubMed ID: 17225322
[No Abstract] [Full Text] [Related]
15. Gemfibrozil in familial and type V hyperlipidaemias. Report of 3 cases.
Varthakavi P; Turakhia DP; Sharma S; Salgaonkar DS; Nihalani KD; Joshi VR
J Assoc Physicians India; 1990 Nov; 38(11):860-2. PubMed ID: 2079473
[TBL] [Abstract][Full Text] [Related]
16. [Various HMG-CoA reductase inhibitors].
Thiery J; Seidel D
Internist (Berl); 1999 Jan; 40(1):113-4. PubMed ID: 10086311
[No Abstract] [Full Text] [Related]
17. [HMG-CoA reductase inhibitors].
Thiery J; Seidel D
Internist (Berl); 1998 Aug; 39(8):866-7. PubMed ID: 9757391
[No Abstract] [Full Text] [Related]
18. Niacin: a therapeutic dilemma. "One man's drink is another's poison".
Kreisberg RA
Am J Med; 1994 Oct; 97(4):313-6. PubMed ID: 7942931
[No Abstract] [Full Text] [Related]
19. Familial combined hyperlipoproteinemia.
Genest J
CMAJ; 1991 Sep; 145(6):664. PubMed ID: 1893322
[No Abstract] [Full Text] [Related]
20. Safety and side effects of sustained-release niacin.
Keenan JM; Ripsin CM; Huang Z; McCaffrey DJ
JAMA; 1994 Aug; 272(7):513; author reply 514-5. PubMed ID: 8046795
[No Abstract] [Full Text] [Related]
[Next] [New Search]
